"Lou Gehrig's Disease"
800.882.5764
24359 Northwestern Hwy., Suite 100
Southfield, MI  48075   Contact Us
Click here to Donate Now!
For 30 years, helping people with ALS (pALS), their families,
and caregivers to live life as fully as possible
Click here to Donate Now!
Walk'n Roll logo

Walk the Extra Mile!


Presented by




Sign up your Walk team or make a contribution in honor of your favorite pALS:


2010 Dates and walk locations:
  • Sunday, September 19 - Hawk Island Park, Lansing
  • Sunday, September 26 - Kensington Metropark, Milford
  • Sunday, September 26 - Stony Creek Metropark, Shelby Twp.
  • Saturday, October 2 - Lake Erie Metropark, Brownstown
  • Breaking News!


    Ceftriaxone Clinical Trials
    The Hiller ALS Center at Wayne State University School of Medicine and Detroit Medical Center, Harry Hoenselaar ALS Clinic at Henry Ford Hospital, and St. Mary's Healthcare are excited to announce that they are now recruiting patients for participation in an NIH sponsored multi-center trial to evaluate the safety and efficacy of intravenous (IV) ceftriaxone treatment in ALS. Drs. Richard Lewis and Agnes Acsadi from Wayne State/DMC; Dr. Dan Newman from Henry Ford; and Dr. Deborah Gelinas from St. Mary's are the investigators.

    Ceftriaxone is an antibiotic that has been utilized for many years in the treatment of bacterial infections. Recent laboratory studies have suggested that ceftriaxone has a protective effect on motor neurons.

    The Hiller ALS Center at Wayne State University School of Medicine and Detroit Medical Center, Harry Hoenselaar ALS Clinic at Henry Ford Hospital, and St. Mary's Healthcare are excited to announce that they are now recruiting patients for participation in an NIH sponsored multi-center trial to evaluate the safety and efficacy of intravenous (IV) ceftriaxone treatment in ALS. Drs. Richard Lewis and Agnes Acsadi from Wayne State/DMC; Dr. Dan Newman from Henry Ford; and Dr. Deborah Gelinas from St. Mary's are the investigators.

    Ceftriaxone is an antibiotic that has been utilized for many years in the treatment of bacterial infections. Recent laboratory studies have suggested that ceftriaxone has a protective effect on motor neurons.

    The study is a double-blinded, placebo controlled study in which 2/3 of the patients will receive the antibiotic and 1/3 will receive the placebo. Because there will be 2 infusions daily, an indwelling catheter will be placed in all patients. People with diagnosed ALS who have had the disease for less than 3 years and have minimal respiratory problems are potentially eligible. Please contact:

    Stacey Masse RN, study co-ordinator
    Wayne State Univeristy/DMC/Hiller ALS Center
    313-745-6124 or by email at smasse@med.wayne.edu.

    Helen Foley, RN, study co-ordinator
    Harry Hoenselaar ALS Clinic/Henry Ford Hospital
    313-916-3955 helen@neuro.hfh.edu

    Brian Berryhill, study co-ordinator
    St. Mary's Healthcare
    616-685-5435 or email berryhib@trinity-health.org

    For more information on the research project visit: Clinical Trials

    Pals Power Our brand new Tribute Fund pages give you a unique opportunity to honor your loved one in a special way and raise funds for our pALS and their families.

    These pages are devoted to Michigan's ALS Community and to those who are courageously battling this disease. However, you are also welcome to set up a fund for any other purpose.

    Create Your Fund Now

    For Our pALS and Families

    CONFERENCES AND WORKSHOPS

    Click here to download the conference brochure
    FRIENDS AND FAMILY EVENTS
    NEW ALS RESEARCH NEWS
    Sept 21, 2009 - Neuralstem, Inc. (NYSE Amex: CUR) today announced that the U.S. Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application to commence a Phase I trial to treat Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's disease) with its spinal cord stem cells. Neuralstem is the first company to commence a stem cell trial to treat ALS.
    Read more »
    ESPECIALLY FOR VETERANS WITH ALS
    We are pleased to announce these new rules from the Department of Veterans Affairs. All veterans with ALS who have served at least 90 days or more of continuous service now have presumptive eligibility.
    Read more »

    We Have Moved!

    Please come visit us at our new offices at:
    24359 Northwestern Highway
    Suite 100
    Southfield, MI 48075
    Our phone numbers remain the same.
    All ALS of Michigan event pictures can now be found on Flickr at www.flickr.com/photos/alsofmichigan
    Order your Hiller's Scrip Card »

    Donate with Confidence


    Are you concerned about how your generous contributions will be used?  Of course you are!

    100% of your contributions stay right here in Michigan helping Michigan pALS and their families.

    Click here now for secure Online Giving: Click here to Donate Now!
    Our services to families, caregivers and patients with ALS (pALS) include support groups, respite care, augmentative and alternative communication, seminars and workshops, loan closet of durable medical equipment, home visits, patient and public information, and much more! -- We also support research into the cause, cure and treatment of ALS.

    Need more information?

    Click here for an information request form.
    Click here for our Patient Resource Manual Page.

    ALS of Michigan is not associated with
    ALSA - The ALS Association
    or with the ALS Association - Michigan Chapter
    Member of Community Health Charities
    Goodsearch logo
    Blue Cross Blue Shield Walking Works For free or low-cost health care coverage for children under the age of 19 - or pregnant women of any age - call the MI Child and Healthy Kids hotline at 1-888-988-6300 or go to https://healthcare4mi.com/michild-web/.